Sign in
4

Changes in Ownership

Seres Therapeutics, Inc. Filed Acc 0000899243-23-004207

Options or other derivatives

  • Chief Legal Officer and EVP acquired 127,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

DesRosier Thomas · Chief Legal Officer and EVP

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-02-03 Grant or award : show line 1 in the form Restricted Stock Units +42,500 42,500 D
2023-02-03 Grant or award : show line 2 in the form Stock Option (Right to Buy) +85,000 85,000 D
Loading xslF345X03/doc4.xml…